US equities |
GOOGL $283.82 ▼-12.64% GOOG $282.32 ▼-12.29% MU $934.27 ▼-4.98% MSFT $530.14 ▼-0.16% AMZN $243.79 ▼-4.25% META $624.52 ▲+1.96% NVDA $213.66 ▼-0.80% AAPL $348.91 ▲+1.48%
FinancialContent

Articles published by Amplia Therapeutics Limited

News headline image
Amplia Signs Collaboration Agreement With Lilly, Evaluating Narmafotinib Plus Lilly’s Kras G12C Inhibitor, Olomorasib, in Non-small Cell Lung Cancer
From Amplia Therapeutics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online
From Amplia Therapeutics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Announces Publication of New FAK Inhibitor Patent Application
From Amplia Therapeutics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Announces Appointment of Brett Carter to Board
From Amplia Therapeutics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Announces Changes to Board’s Leadership Roles
From Amplia Therapeutics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
From Amplia Therapeutics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF